(Q42595600)

3 November 2017

title

Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation (English)

1 reference

3 November 2017

Lorenzo Magri

4

0 references

Adele Pirovano

object named as

Adele Pirovano

6

0 references

Cristina Lorenzi

object named as

Cristina Lorenzi

5

0 references

Enrico Smeraldi

8

object named as

Enrico Smeraldi

1 reference

3 November 2017

9

Raffaella Zanardi

1 reference

3 November 2017

2

David Rossini

1 reference

3 November 2017

Alessia Malaguti

1

1 reference

3 November 2017

Adelio Lucca

3

1 reference

3 November 2017

Christina Colombo

7

1 reference

3 November 2017

language of work or name

1 reference

29 March 2011

1 reference

3 November 2017

published in

Depression and Anxiety

1 reference

3 November 2017

volume

28

1 reference

3 November 2017

issue

7

1 reference

3 November 2017

page(s)

568-573

1 reference

A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression.

3 November 2017

cites work

1 reference

Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression

21 January 2018

1 reference

Reduction of prefrontal cortex glucose metabolism common to three types of depression

21 January 2018

1 reference

Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis

21 January 2018

1 reference

Predictors of antidepressant response in clinical trials of transcranial magnetic stimulation

21 January 2018

1 reference

Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial

21 January 2018

1 reference

5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression.

21 January 2018

1 reference

A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS.

21 January 2018

1 reference

Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression

21 January 2018

1 reference

Changes in 5-HT1A and NMDA binding sites by a single rapid transcranial magnetic stimulation procedure in rats

21 January 2018

1 reference

Chronic repetitive transcranial magnetic stimulation alters beta-adrenergic and 5-HT2 receptor characteristics in rat brain

21 January 2018

1 reference

Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain

21 January 2018

1 reference

Modulation of monoamine transporter expression and function by repetitive transcranial magnetic stimulation

21 January 2018

1 reference

Acute prefrontal cortex TMS in healthy volunteers: effects on brain 11C-alphaMtrp trapping

21 January 2018

1 reference

Allelic Variation of Human Serotonin Transporter Gene Expression

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system

21 January 2018

1 reference

Acute repetitive transcranial magnetic stimulation reactivates dopaminergic system in lesion rats

21 January 2018

1 reference

Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study

21 January 2018

1 reference

rTMS of the left dorsolateral prefrontal cortex modulates dopamine release in the ipsilateral anterior cingulate cortex and orbitofrontal cortex

21 January 2018

1 reference

The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression

21 January 2018

1 reference

The catechol-O-methyltransferase Val(108/158)Met polymorphism affects antidepressant response to paroxetine in a naturalistic setting

21 January 2018

1 reference

Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism.

21 January 2018

1 reference

Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder

21 January 2018

1 reference

Best estimate of lifetime psychiatric diagnosis: a methodological study.

21 January 2018

1 reference

Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996

21 January 2018

1 reference

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

The value of neuronavigated rTMS for the treatment of depression

21 January 2018

1 reference

5-HT 1A polymorphism and self-transcendence in mood disorders

21 January 2018

1 reference

The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants

21 January 2018

1 reference

Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings

21 January 2018

1 reference

From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes

21 January 2018

1 reference

Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram

21 January 2018

1 reference

Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder.

21 January 2018

1 reference

The 5-HT1A receptor: signaling, desensitization, and gene transcription

21 January 2018

1 reference

How long should pindolol be associated with paroxetine to improve the antidepressant response?

21 January 2018

1 reference

Exposure to AC and DC magnetic fields induces changes in 5-HT1B receptor binding parameters in rat brain membranes.

21 January 2018

1 reference

Influence of the serotonin transporter gene-linked polymorphic region on the antidepressant response to fluvoxamine in Japanese depressed patients.

21 January 2018

1 reference

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin

21 January 2018

1 reference

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

21 January 2018

1 reference

The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder

21 January 2018

1 reference

Pooling pharmacogenetic studies on the serotonin transporter: a mega-analysis.

21 January 2018

1 reference

Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy

21 January 2018

1 reference

Role of serotonergic gene polymorphisms on response to transcranial magnetic stimulation in depression

21 January 2018

1 reference

Efficacy of Paroxetine in Depression Is Influenced by a Functional Polymorphism Within the Promoter of the Serotonin Transporter Gene

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus.

21 January 2018

1 reference

7 January 2021

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders.

1 reference

7 January 2021

Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine

1 reference

7 January 2021

HF-rTMS treatment in medication-resistant melancholic depression: results from 18FDG-PET brain imaging

1 reference

7 January 2021

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1 reference

7 January 2021

Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study

1 reference

7 January 2021

Serotonin transporter gene polymorphism and antidepressant response

1 reference

7 January 2021

Allelic variation in the serotonin transporter promoter affects onset of paroxetine treatment response in late-life depression

1 reference

7 January 2021

Catechol-O-methyltransferase (COMT) polymorphisms predict treatment response in electroconvulsive therapy

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.20815

1 reference

3 November 2017

1 reference